Back to trial details

Intake questionnaire

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Applying to Rutgers Cancer Institute of New Jersey · New Brunswick, New Jersey

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with NSCLC, Stage I?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to New Brunswick for study visits?